Physician

Adam Benjamin Weiner, MD

According to 2025 Medicare claims, Adam Weiner, MD (NPI: 1104288356) practices urology in the Los Angeles-Long Beach-Glendale, CA market, with the plurality of this provider's patient population coming from Los Angeles, CA. This provider's primary affiliated billing organization is CEDARS-SINAI MEDICAL CENTER (NPI: 1639172372; TIN: 951644600) and primary practice location at 90048-1804.

Weiner's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 50 traditional Medicare patients, billed 89 HCPCS/CPT codes, and received $11,034 in Medicare payments. Part D data shows 191 prescription claims across 108 beneficiaries totaling $76,761 in drug costs, led by Myrbetriq (Mirabegron). 2017 DME data shows 11 claims. Open Payments data shows 9 records totaling $601. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have risen steadily, from $608 to $76,761. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$6.8K$14K2022 Medicare payment: $9,486 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $13,577 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $11,034 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
202260828$9,486
2023631,526$13,577
20245089$11,034

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$347K$694K2016 Drug cost: $608 (USD; Tot_Drug_Cst)2017 Drug cost: $7,437 (USD; Tot_Drug_Cst)2018 Drug cost: $488 (USD; Tot_Drug_Cst)2019 Drug cost: $610 (USD; Tot_Drug_Cst)2020 Drug cost: $3,182 (USD; Tot_Drug_Cst)2021 Drug cost: $10,016 (USD; Tot_Drug_Cst)2022 Drug cost: $86,167 (USD; Tot_Drug_Cst)2023 Drug cost: $693,599 (USD; Tot_Drug_Cst)2024 Drug cost: $76,761 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
20162028$608
20173044$7,437
20181120$488
20191822$610
2020N/R12$3,182
20216495$10,016
2022246358$86,167
20233881,161$693,599
2024108191$76,761

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$333$6662017 Medicare payment: $666 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/R11$666
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Part B summary data is connected for 2024, but public code-level payment amounts are not available, so a Top 5 by total payments cannot be shown.

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
MyrbetriqMirabegron15990$14,543
Tamsulosin HclTamsulosin Hcl554,470$851
FinasterideFinasteride443,780$545
PrednisonePrednisone12480$55

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.9$601Astellas Pharma US Inc
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Adam Benjamin Weiner, MD?

Tedicare shows public-source Medicare data for Adam Benjamin Weiner, MD (NPI 1104288356), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adam Benjamin Weiner, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Adam Benjamin Weiner, MD?

Adam Benjamin Weiner, MD is linked to CEDARS-SINAI MEDICAL CENTER (billing NPI 1639172372) in the available physician profile data.

Does Adam Benjamin Weiner, MD have Open Payments data?

Adam Benjamin Weiner, MD has 9 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.